Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ellen M Basu

3PUBLICATIONS
10CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Mar 11, 2025
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission.

Brian H Kushner, Shakeel Modak, Audrey Mauguen

|Jun 27, 2024
Long Prime-Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine.

Irene Y Cheung, Audrey Mauguen, Shakeel Modak

|Nov 26, 2019
Entrectinib in Two Pediatric Patients With Inflammatory Myofibroblastic Tumors Harboring <i>ROS1</i> or <i>ALK</i> Gene Fusions.

Srikanth R Ambati, Emily K Slotkin, Edna Chow-Maneval

Pageof 1

Frequent Collaborators

2 joint publications

Irene Y Cheung

2 joint publications

Nai-Kong V Cheung

1 joint publications

Srikanth R Ambati

1 joint publications

Emily K Slotkin

1 joint publications

Edna Chow-Maneval

1 joint publications

Brian H Kushner

1 joint publications

Shakeel Modak

1 joint publications

Audrey Mauguen

1 joint publications

Kim Kramer

1 joint publications

Stephen S Roberts

Frequent Collaborators

2 joint publications

Irene Y Cheung

2 joint publications

Nai-Kong V Cheung

1 joint publications

Srikanth R Ambati

1 joint publications

Emily K Slotkin

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.0K
Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8<sup>+</sup> T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8<sup>+</sup> T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on : Nov 28, 2018

8.6K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on : Feb 17, 2022

3.7K
See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.0K
Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8<sup>+</sup> T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8<sup>+</sup> T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on : Nov 28, 2018

8.6K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on : Feb 17, 2022

3.7K
See more related videos